EAM
ZBH icon

Exos Asset Management’s Zimmer Biomet ZBH Stock Holding History

Exos Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-563
Closed -$88K – 717
2021
Q2 		$88K Buy
+563
New +$91.2K 0.05% 367

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Exos Asset Management's ZBH Position: Q3 2021 in Review

Exos Asset Management sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 563 shares — an estimated $88K sold.

Exos Asset Management first reported a position in ZBH in Q2 2021 and held it in 1 quarter. The position peaked at $88K in Q2 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

  • Exos Asset Management reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
  • Exos Asset Management sold 563 Zimmer Biomet shares in Q3 2021, an estimated $88K.
  • Exos Asset Management first reported a position in Zimmer Biomet in Q2 2021 and held it in 1 quarter.
  • Exos Asset Management's Zimmer Biomet position peaked at $88K in Q2 2021.
  • 982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Exos Asset Management's 13F filing for Q3 2021, filed 25 Oct 2021.